Ryan Specialty Holdings, Inc. (NYSE:RYAN) Receives $71.67 Consensus PT from Analysts

Ryan Specialty Holdings, Inc. (NYSE:RYANGet Free Report) has received a consensus recommendation of “Hold” from the eleven ratings firms that are presently covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, five have given a hold rating and five have issued a buy rating on the company. The average twelve-month price target among brokers that have covered the stock in the last year is $71.67.

Several equities research analysts have weighed in on the company. Barclays raised their price target on Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a report on Thursday, November 21st. Wells Fargo & Company lifted their target price on shares of Ryan Specialty from $63.00 to $70.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 10th. Bank of America upped their price target on shares of Ryan Specialty from $75.00 to $84.00 and gave the company a “buy” rating in a research note on Thursday, October 10th. BMO Capital Markets upgraded shares of Ryan Specialty from a “market perform” rating to an “outperform” rating and lifted their price objective for the stock from $65.00 to $75.00 in a research note on Tuesday, September 24th. Finally, The Goldman Sachs Group upped their target price on Ryan Specialty from $64.00 to $72.00 and gave the company a “neutral” rating in a research report on Wednesday, October 9th.

Read Our Latest Research Report on RYAN

Insider Buying and Selling at Ryan Specialty

In other news, EVP Mark Stephen Katz sold 14,790 shares of the firm’s stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $71.39, for a total transaction of $1,055,858.10. Following the sale, the executive vice president now owns 12,386 shares of the company’s stock, valued at $884,236.54. This trade represents a 54.42 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director David P. Bolger sold 7,055 shares of the business’s stock in a transaction on Thursday, November 21st. The shares were sold at an average price of $70.88, for a total transaction of $500,058.40. Following the completion of the transaction, the director now owns 78,149 shares of the company’s stock, valued at approximately $5,539,201.12. This represents a 8.28 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 11.10% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Ryan Specialty

A number of large investors have recently bought and sold shares of RYAN. Tidal Investments LLC increased its holdings in Ryan Specialty by 30.4% in the 3rd quarter. Tidal Investments LLC now owns 12,255 shares of the company’s stock worth $814,000 after acquiring an additional 2,858 shares in the last quarter. Wilmington Savings Fund Society FSB acquired a new stake in shares of Ryan Specialty in the third quarter valued at about $193,000. Sanctuary Advisors LLC increased its stake in shares of Ryan Specialty by 11.9% during the third quarter. Sanctuary Advisors LLC now owns 15,502 shares of the company’s stock worth $1,140,000 after purchasing an additional 1,651 shares in the last quarter. Virtu Financial LLC acquired a new position in shares of Ryan Specialty during the 3rd quarter worth about $263,000. Finally, Teachers Retirement System of The State of Kentucky lifted its stake in Ryan Specialty by 51.5% in the 3rd quarter. Teachers Retirement System of The State of Kentucky now owns 30,760 shares of the company’s stock valued at $2,042,000 after buying an additional 10,460 shares in the last quarter. Institutional investors and hedge funds own 84.82% of the company’s stock.

Ryan Specialty Trading Up 0.4 %

NYSE:RYAN opened at $75.40 on Friday. The stock has a market capitalization of $19.74 billion, a price-to-earnings ratio of 97.92, a PEG ratio of 1.71 and a beta of 0.62. Ryan Specialty has a 52 week low of $41.49 and a 52 week high of $75.97. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40. The firm has a 50 day moving average of $70.23 and a 200 day moving average of $63.34.

Ryan Specialty (NYSE:RYANGet Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $0.41 EPS for the quarter, meeting the consensus estimate of $0.41. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. The firm had revenue of $604.69 million during the quarter, compared to analyst estimates of $602.04 million. During the same quarter in the prior year, the business posted $0.32 EPS. The business’s revenue for the quarter was up 20.5% compared to the same quarter last year. As a group, sell-side analysts anticipate that Ryan Specialty will post 1.8 earnings per share for the current fiscal year.

Ryan Specialty Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, November 26th. Investors of record on Tuesday, November 12th were given a dividend of $0.11 per share. The ex-dividend date was Tuesday, November 12th. This represents a $0.44 dividend on an annualized basis and a yield of 0.58%. Ryan Specialty’s dividend payout ratio is presently 57.14%.

About Ryan Specialty

(Get Free Report

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Featured Stories

Analyst Recommendations for Ryan Specialty (NYSE:RYAN)

Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.